Espacio reservado para banners y logos institucionales

SABER UCV >  1) Investigación >  Artículos Publicados > 

> Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis)
Please use this identifier to cite or link to this item: https://saber.ucv.ve/handle/10872/12318

Title: Immunopathologic study of erythema dyschromicum perstans (ashy dermatosis)
Authors: Vásquez-Ochoa, Luz A.
Isaza-Guzmán, Diana M.
Orozco-Mora, Beatriz
Restrepo-Molina, Rodrigo
Trujillo-Perez, Judith
Tapia, Félix J.
Keywords: Immunopathologic
dermatosis
Issue Date: 2006
Publisher: Tropical medicine rounds
Abstract: Erythema dyschromicum perstans (EDP) is a pigmentary disease of unknown etiology in which damage to basal cells is thought to be mediated by adhesion molecules. The aim of this study was to characterize the histopathology and immunopathology of EDP. Forty-three patients from Medellín, Colombia, with the diagnosis of EDP were evaluated. Skin biopsy specimens were obtained for histopathology and immunohistochemistry, using monoclonal antibodies directed against the following markers: CD4, CD8, CD56, CD1a, CD68, CLA, HLA–DR, ICAM-1 and LFA-1 α . A dermal lymphocytic infiltrate was observed in all cases, with a perivascular location in 86%. Other histologic features included melanophages in all specimens, vacuolization of the basement membrane zone (BMZ) 58% and exocytosis of lymphocytes (53.5%). The mean number of total leukocytes was 1510 cells mm − 2 of tissue. There was a predominance of CD8 + T lymphocytes in the dermis and HLA–DR + , ICAM-1 + keratinocytes in the epidermis. Exocytosis of cutaneous lymphocyte antigen (CLA) + cells was observed in areas of BMZ damage, suggesting that response to antigenic stimulation may play a role in the development of EDP.
URI: http://hdl.handle.net/10872/12318
Appears in Collections:Artículos Publicados

Files in This Item:

File Description SizeFormat
Immunopathology of ashy dermatosis.pdf151.3 kBAdobe PDFView/Open
View Statistics

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.